These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
273 related items for PubMed ID: 33077922
1. Targeted RNA expression profiling identifies high-grade endometrial stromal sarcoma as a clinically relevant molecular subtype of uterine sarcoma. Momeni-Boroujeni A, Mohammad N, Wolber R, Yip S, Köbel M, Dickson BC, Hensley ML, Leitao MM, Antonescu CR, Benayed R, Ladanyi M, Lee CH, Chiang S. Mod Pathol; 2021 May; 34(5):1008-1016. PubMed ID: 33077922 [Abstract] [Full Text] [Related]
2. High-grade Endometrial Stromal Sarcoma: Morphologic and Clinical Features, the Role of Immunohistochemistry and Fluorescence in Situ Hybridization in Diagnosis. Alkanat NE, Uner A, Usubutun A. Int J Surg Pathol; 2023 Aug; 31(5):521-531. PubMed ID: 35506912 [Abstract] [Full Text] [Related]
3. Endometrial stromal sarcomas with BCOR-rearrangement harbor MDM2 amplifications. Kommoss FK, Chang KT, Stichel D, Banito A, Jones DT, Heilig CE, Fröhling S, Sahm F, Stenzinger A, Hartmann W, Mechtersheimer G, Sinn HP, Schmidt D, Kommoss F, von Deimling A, Koelsche C. J Pathol Clin Res; 2020 Jul; 6(3):178-184. PubMed ID: 32352245 [Abstract] [Full Text] [Related]
4. Undifferentiated Uterine Sarcomas Represent Under-Recognized High-grade Endometrial Stromal Sarcomas. Cotzia P, Benayed R, Mullaney K, Oliva E, Felix A, Ferreira J, Soslow RA, Antonescu CR, Ladanyi M, Chiang S. Am J Surg Pathol; 2019 May; 43(5):662-669. PubMed ID: 30789359 [Abstract] [Full Text] [Related]
5. Endometrial Stromal Sarcomas With BCOR Internal Tandem Duplication and Variant BCOR/BCORL1 Rearrangements Resemble High-grade Endometrial Stromal Sarcomas With Recurrent CDK4 Pathway Alterations and MDM2 Amplifications. Kommoss FKF, Chiang S, Köbel M, Koelsche C, Chang KT, Irving JA, Dickson B, Thiryayi S, Rouzbahman M, Rasty G, von Deimling A, Lee CH, Turashvili G. Am J Surg Pathol; 2022 Aug 01; 46(8):1142-1152. PubMed ID: 35499168 [Abstract] [Full Text] [Related]
6. BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology. Chiang S, Lee CH, Stewart CJR, Oliva E, Hoang LN, Ali RH, Hensley ML, Arias-Stella JA, Frosina D, Jungbluth AA, Benayed R, Ladanyi M, Hameed M, Wang L, Kao YC, Antonescu CR, Soslow RA. Mod Pathol; 2017 Sep 01; 30(9):1251-1261. PubMed ID: 28621321 [Abstract] [Full Text] [Related]
7. Diagnostic Value of Combined BCOR, Cyclin D1, and CD10 in Differentiating Endometrial Stromal Sarcoma From Other Uterine Spindle Cell Lesions. Abouelkhair MB, Shakweer MM, Faisal MM, Nasreldin MH, Farid LM. Appl Immunohistochem Mol Morphol; 2024 Aug 01; 32(7):326-335. PubMed ID: 38961542 [Abstract] [Full Text] [Related]
8. BCOR Internal Tandem Duplication in High-grade Uterine Sarcomas. Mariño-Enriquez A, Lauria A, Przybyl J, Ng TL, Kowalewska M, Debiec-Rychter M, Ganesan R, Sumathi V, George S, McCluggage WG, Nucci MR, Lee CH, Fletcher JA. Am J Surg Pathol; 2018 Mar 01; 42(3):335-341. PubMed ID: 29200103 [Abstract] [Full Text] [Related]
9. ZC3H7B-BCOR high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entity. Lewis N, Soslow RA, Delair DF, Park KJ, Murali R, Hollmann TJ, Davidson B, Micci F, Panagopoulos I, Hoang LN, Arias-Stella JA, Oliva E, Young RH, Hensley ML, Leitao MM, Hameed M, Benayed R, Ladanyi M, Frosina D, Jungbluth AA, Antonescu CR, Chiang S. Mod Pathol; 2018 Apr 01; 31(4):674-684. PubMed ID: 29192652 [Abstract] [Full Text] [Related]
10. Uterine Endometrial Stromal Tumors With Pure Low-Grade Morphology Harboring YWHAE::NUTM2 Fusions: Report of a Case Series Emphasizing Potential for High-Grade Transformation and Aggressive Behavior. Devins KM, Attygalle AD, Croce S, Vroobel K, Oliva E, McCluggage WG. Am J Surg Pathol; 2023 Jun 01; 47(6):717-724. PubMed ID: 37032555 [Abstract] [Full Text] [Related]
11. Highly Invasive and Metastatic High-grade Endometrial Stromal Sarcoma With BCOR Gene Alterations: A Case Report. Ling F, Ruan S, Chen H, Xiong X, Zhao D, Haybaeck J, Zhang C. In Vivo; 2022 Jun 01; 36(4):1971-1976. PubMed ID: 35738637 [Abstract] [Full Text] [Related]
12. NTRK Fusions Define a Novel Uterine Sarcoma Subtype With Features of Fibrosarcoma. Chiang S, Cotzia P, Hyman DM, Drilon A, Tap WD, Zhang L, Hechtman JF, Frosina D, Jungbluth AA, Murali R, Park KJ, Soslow RA, Oliva E, Iafrate AJ, Benayed R, Ladanyi M, Antonescu CR. Am J Surg Pathol; 2018 Jun 01; 42(6):791-798. PubMed ID: 29553955 [Abstract] [Full Text] [Related]
13. [Clinicopathological study of BCOR rearrangement in high grade endometrial stromal sarcoma]. Cheng YF, Bai QM, Bi R, Chang B, Huang D, Yu L, Zhou XY, Yang WT, Tu XY. Zhonghua Bing Li Xue Za Zhi; 2019 Aug 08; 48(8):604-609. PubMed ID: 31422590 [Abstract] [Full Text] [Related]
14. Genomic profiling of BCOR-rearranged uterine sarcomas reveals novel gene fusion partners, frequent CDK4 amplification and CDKN2A loss. Lin DI, Hemmerich A, Edgerly C, Duncan D, Severson EA, Huang RSP, Ramkissoon SH, Connor YD, Shea M, Hecht JL, Ali SM, Vergilio JA, Ross JS, Elvin JA. Gynecol Oncol; 2020 May 08; 157(2):357-366. PubMed ID: 32156473 [Abstract] [Full Text] [Related]
15. NTRK3 overexpression in undifferentiated sarcomas with YWHAE and BCOR genetic alterations. Kao YC, Sung YS, Argani P, Swanson D, Alaggio R, Tap W, Wexler L, Dickson BC, Antonescu CR. Mod Pathol; 2020 Jul 08; 33(7):1341-1349. PubMed ID: 32034283 [Abstract] [Full Text] [Related]
16. YWHAE rearrangement identified by FISH and RT-PCR in endometrial stromal sarcomas: genetic and pathological correlations. Croce S, Hostein I, Ribeiro A, Garbay D, Velasco V, Stoeckle E, Guyon F, Floquet A, Neuville A, Coindre JM, MacGrogan G, Chibon F. Mod Pathol; 2013 Oct 08; 26(10):1390-400. PubMed ID: 23599159 [Abstract] [Full Text] [Related]
17. Genomic and Transcriptomic Characterization Revealed the High Sensitivity of Targeted Therapy and Immunotherapy in a Subset of Endometrial Stromal Sarcoma. Kang N, Zhang Y, Guo S, Chen R, Kong F, Wang S, Yuan M, Chen R, Shen D, Wang J. Cancer Res Treat; 2023 Jul 08; 55(3):978-991. PubMed ID: 36731460 [Abstract] [Full Text] [Related]